C. Elie

发表

Rapid Identification of Candida Species with Species-Specific DNA Probes

T. Lott, C. J. Morrison, C. Elie, 1998, Journal of Clinical Microbiology.

An Analytical Model Applied to a Multicenter Pneumococcal Enzyme-Linked Immunosorbent Assay Study

I. Jónsdóttir, B. Plikaytis, D. Goldblatt, 2000, Journal of Clinical Microbiology.

Immune responses to Bacillus anthracis protective antigen in patients with bioterrorism-related cutaneous or inhalation anthrax.

Sandra K. Martin, R. Ahmed, S. Crotty, 2004, The Journal of infectious diseases.

Specific, Sensitive, and Quantitative Enzyme-Linked Immunosorbent Assay for Human Immunoglobulin G Antibodies to Anthrax Toxin Protective Antigen

Lilah M. Besser, Sandra K. Martin, J. Sejvar, 2002, Emerging infectious diseases.

Predictors of immunity after a major serogroup W-135 meningococcal disease epidemic, Burkina Faso, 2002.

T. Popović, B. Plikaytis, S. Johnson, 2006, The Journal of infectious diseases.

An analytical model applied to a multicenter pneumococcal enzyme-linked immunosorbent assay study.

I. Jónsdóttir, B. Plikaytis, D. Goldblatt, 2000, Journal of clinical microbiology.

Specificity of the Antibody Response to the Pneumococcal Polysaccharide and Conjugate Vaccines in Human Immunodeficiency Virus-Infected Adults

C. Whitney, W. O'brien, R. Breiman, 2004, Clinical Diagnostic Laboratory Immunology.

Randomized trial of the quantitative and functional antibody responses to a 7-valent pneumococcal conjugate vaccine and/or 23-valent polysaccharide vaccine among HIV-infected adults.

C. Whitney, W. O'brien, R. Breiman, 2001, Vaccine.

Antibody responses in postsplenectomy trauma patients receiving the 23-valent pneumococcal polysaccharide vaccine at 14 versus 28 days postoperatively.

S. Romero-Steiner, G. Carlone, D. Shatz, 2002, The Journal of trauma.

Human Complement Bactericidal Responses to a Group A Meningococcal Conjugate Vaccine in Africans and Comparison to Responses Measured by 2 Other Group A Immunoassays.

Gregory A. Price, B. Plikaytis, G. Carlone, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Comparison of a New Colorimetric Assay with the NCCLS Broth Microdilution Method (M-27A) for Antifungal Drug MIC Determination

M. Ciblak, C. Elie, G. E. Clayton, 2000, Journal of Clinical Microbiology.

Investigation of Different Group A Immunoassays following One Dose of Meningococcal Group A Conjugate Vaccine or A/C Polysaccharide Vaccine in Adults

B. Plikaytis, G. Carlone, E. Marchetti, 2009, Clinical and Vaccine Immunology.

Antibody Persistence at 1 and 4 Years Following a Single Dose of MenAfriVac or Quadrivalent Polysaccharide Vaccine in Healthy Subjects Aged 2–29 Years

R. Adegbola, Yuxiao Tang, B. Plikaytis, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Safety, immunogenicity, and antibody persistence of a new meningococcal group A conjugate vaccine in healthy Indian adults.

N. Gogtay, U. Thatte, B. Plikaytis, 2007, Vaccine.

Physiological characteristics and mycotoxins of human clinical isolates of Fusarium species

J. Brock, D. Barr, D. Patterson, 1999 .

Sequence Analysis of the Internal Transcribed Spacer 2 (ITS2) from Yeast Species Within the Genus Candida

T. Lott, R. Zancopé-Oliveira, C. Elie, 1998, Current Microbiology.

Molecular epidemiology of Candida albicans strains isolated from the oropharynx of HIV-positive patients at successive clinic visits.

D. Rimland, R. Kuykendall, M. McNeil, 2001, Medical mycology.

Rapid and unequivocal differentiation of Candida dubliniensis from other Candida species using species-specific DNA probes: comparison with phenotypic identification methods.

C J Morrison, A. Ellepola, C. J. Morrison, 2003, Oral microbiology and immunology.

The impact of pre-existing antibody on subsequent immune responses to meningococcal A-containing vaccines.

B. Plikaytis, G. Carlone, M. Ota, 2014, Vaccine.

Immunologic memory 5 years after meningococcal A/C conjugate vaccination in infancy.

J. Deeks, B. Greenwood, G. Carlone, 2001, The Journal of infectious diseases.

Opening a bacillus anthracis-containing envelope, Capitol Hill, Washington, D.C.: the public health response.

Sandra Romero-Steiner, A. Schuchat, R. Khabbaz, 2002, Emerging infectious diseases.

The Public Health Response and Epidemiologic Investigation Related to the Opening of a Bacillus anthracis–Containing Envelope, Capitol Hill, Washington, D.C.

A. Schuchat, R. Khabbaz, Ali S Khan, 2002, Emerging Infectious Diseases.

No evidence of a mild form of inhalational Bacillus anthracis infection during a bioterrorism-related inhalational anthrax outbreak in Washington, D.C., in 2001.

J. Jernigan, S. Fridkin, S. Romero-Steiner, 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Inhalational Anthrax Outbreak among Postal Workers, Washington, D.C., 2001

Sandra Romero-Steiner, Alicia M. Fry, Kevin L. Winthrop, 2002, Emerging infectious diseases.

Viral load response to a pneumococcal conjugate vaccine, polysaccharide vaccine or placebo among HIV-infected patients.

W. O'brien, R. Breiman, D. Feikin, 2002, AIDS.

Immunogenicity and safety of a meningococcal A conjugate vaccine in Africans.

D. Diop, R. Adegbola, Yuxiao Tang, 2011, The New England journal of medicine.

Antibody Persistence 1–5 Years Following Vaccination With MenAfriVac in African Children Vaccinated at 12–23 Months of Age

R. Adegbola, Yuxiao Tang, B. Plikaytis, 2015, Clinical Infectious Diseases.

Immunogenicity and safety of a new meningococcal A conjugate vaccine in Indian children aged 2-10 years: a phase II/III double-blind randomized controlled trial.

Yuxiao Tang, B. Plikaytis, S. Juvekar, 2012, Vaccine.

Molecular epidemiology of Candida albicans strains isolated from the oropharynx of HIV-positive patients at successive clinic visits.

D. Rimland, R. Kuykendall, M. McNeil, 2001, Medical mycology.